GENETIC MODIFIERS OF SICKLE CELL DISEASE

被引:21
|
作者
Thein, Swee Lay [1 ,2 ]
机构
[1] Kings Coll London, Dept Mol Haematol, James Black Ctr, London SE5 9NU, England
[2] Kings Coll Hosp Natl Hlth Serv Fdn Trust, Dept Haematol Med, London, England
关键词
Sickle cell disease; Genetic association studies; Genome-wide association studies (GWAS); FETAL-HEMOGLOBIN PRODUCTION; QUANTITATIVE-TRAIT LOCUS; GENOME-WIDE ASSOCIATION; FACTOR KLF1 CAUSES; ALPHA-THALASSEMIA; TRANSCRIPTION FACTOR; RISK-FACTOR; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; PROMOTER POLYMORPHISMS; BETA-THALASSEMIA;
D O I
10.3109/03630269.2011.615876
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sickle cell disease is one of the best characterized human monogenic disorders. Complex genotype/phenotype correlations clearly demonstrate the interaction of multiple genetic and environmental factors. In the last 20 years, scientific research has applied genetic approaches to dissect some of these modifiers. This review highlights the more recent genetic association studies that have been applied to unravel the genetic modifiers of sickle cell disease including Hb F genetics, and the key genetic variants identified. Illumination of such modifying factors may guide future therapeutic interventions and improve prediction of disease severity, with implications for genetic counseling, prenatal diagnosis and implementation of high risk therapy.
引用
收藏
页码:589 / 606
页数:18
相关论文
共 50 条
  • [31] Genetic therapies for sickle cell disease
    Esrick, Erica B.
    Bauer, Daniel E.
    SEMINARS IN HEMATOLOGY, 2018, 55 (02) : 76 - 86
  • [32] Genetic complexity in sickle cell disease
    Higgs, Douglas R.
    Wood, William G.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (33) : 11595 - 11596
  • [33] Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease
    Diamantidis, Michael D.
    Ikonomou, Georgia
    Argyrakouli, Ioanna
    Pantelidou, Despoina
    Delicou, Sophia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
  • [34] A Genome Wide Association Study to investigate genetic risk modifiers of leg ulcers in adults with sickle cell disease
    Connors, Jordan
    Middlebrooks, Candace
    Buscetta, Ashley
    Minniti, Caterina
    Musolf, Anthony
    Bailey-Wilson, Joan
    Bonham, Vence
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 701 - 702
  • [35] Genetic Analyses in the Uganda Sickle Surveillance Study: Modifiers of Sickle Cell Anemia and Identification of Hemoglobin Variants
    Schaefer, Beverly A.
    Kiyaga, Charles
    Howard, Thad A.
    Ndeezi, Grace
    Hernandez, Arielle G.
    Ssewanyana, Isaac
    Paniagua, Mary C.
    Ndugwa, Christopher
    Aceng, Jane
    Ware, Russell E.
    BLOOD, 2016, 128 (22)
  • [36] Genetic modifiers of cerebrovascular large vessel stenosis in sickle cell anemia.
    Driscoll, MC
    Devaney, J
    Gordish, H
    Minniti, C
    Hoffman, EP
    BLOOD, 2004, 104 (11) : 461A - 461A
  • [37] Regulators of erythrocyte volume as modifiers in sickle cell disease: The Gardos channel
    Tian, Charles
    Okam, Maureen
    Alper, Seth L.
    Steinberg, Martin H.
    Brugnara, Carlo
    Gallagher, Patrick G.
    BLOOD, 2007, 110 (11) : 992A - 993A
  • [38] THE POSSIBLE ROLE OF GENETIC MODIFIERS IN THE CLINICAL SEVERITY OF SICKLE-CELL SYNDROMES
    PIOMELLI, S
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1989, 565 : 207 - 210
  • [39] THE POSSIBLE ROLE OF GENETIC MODIFIERS IN THE CLINICAL SEVERITY OF SICKLE-CELL SYNDROMES
    PIOMELLI, S
    SICKLE CELL DISEASE /, 1989, 565 : 207 - 210
  • [40] Extensive admixture in Brazilian sickle cell patients: implications for the mapping of genetic modifiers
    da Silva, Maria Clara F.
    Zuccherato, Luciana W.
    Lucena, Flavia C.
    Soares-Souza, Giordano B.
    Vieira, Zilma M.
    Pena, Sergio D. J.
    Martins, Marina L.
    Tarazona-Santos, Eduardo
    BLOOD, 2011, 118 (16) : 4493 - 4495